The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2022

Filed:

Mar. 05, 2018
Applicant:

Jiangsu Rongtai Biotech Co., Ltd., Nanjing, CN;

Inventor:

Hanmei Xu, Nanjing, CN;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); A61P 27/02 (2006.01); A61P 9/00 (2006.01); A61P 19/02 (2006.01); A61P 27/16 (2006.01); A61P 29/00 (2006.01); A61K 38/00 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70557 (2013.01); A61K 38/00 (2013.01); A61P 9/00 (2018.01); A61P 19/02 (2018.01); A61P 27/02 (2018.01); A61P 27/16 (2018.01); A61P 29/00 (2018.01); C07K 14/4703 (2013.01); C07K 2319/30 (2013.01);
Abstract

The invention discloses a fusion protein, preparation method thereof and use thereof and belongs to the field of biopharmaceutical technology. The fusion protein according to the present invention has anti-tumor, anti-autoimmune diseases and anti-inflammatory functions, and therapeutic effects on ophthalmic diseases. According to the long-acting, multifunctional fusion protein of the present invention, the EDSM-Y or EDSM-X polypeptide is fused to the antibody immunoglobulin Fc fragment by a flexible linker so as to obtain the fusion proteins I-V, which can improve the efficacy, prolong the half-life and enhance stability, have characteristics of strong effect, low toxicity and the like, and can be used for the prevention and treatment of solid tumors and various types of inflammation and neovascular ophthalmic diseases. The fusion protein is expressed in a prokaryotic cell or a eukaryotic cell by a genetic engineering method, and the expressed fusion protein is obtained by affinity chromatography.


Find Patent Forward Citations

Quick Actions:

Xu, Hanmei. (2022). Fusion protein, preparation method therefor and use thereof (U.S. Patent No. 11407811). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11407811

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…